Alnylam Pharmaceuticals Inc (ALNY) Insider Trading
- $71,277,732.32
- $381,826,108.55
- Aug. 20, 2024
- Akshay Vaishnaw
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
Aug. 20, 2024 | CEO | 15,000 | $280.00 | Sell | $4,200,000.00 | |
Aug. 6, 2024 | Director | 20,250 | $262.00 | Sell | $5,305,500.00 | |
Aug. 1, 2024 | CEO | 15,148 | $270.00 | Sell | $4,089,960.00 | |
July 11, 2024 | CEO | 7,093 | $261.00 | Sell | $1,851,273.00 | |
June 25, 2024 | CMO | 2,103 | $230.99 | Sell | $485,771.97 | |
June 25, 2024 | CFO | 1,605 | $231.00 | Sell | $370,755.00 | |
June 25, 2024 | CEO | 8,301 | $230.99 | Sell | $1,917,447.99 | |
June 25, 2024 | EVP | 1,198 | $230.99 | Sell | $276,726.02 | |
June 24, 2024 | Director | 32,450 | $220.69 | Sell | $7,161,390.50 | |
May 29, 2024 | Director | 21,700 | $148.60 | Sell | $3,224,620.00 | |
Dec. 27, 2023 | Director | 30,000 | $195.00 | Sell | $5,850,000.00 | |
Aug. 7, 2023 | CMO | 4,166 | $183.89 | Sell | $766,085.74 | |
Aug. 4, 2023 | CEO | 4,057 | $185.85 | Sell | $753,993.45 | |
Aug. 4, 2023 | CMO | 3,461 | $185.85 | Sell | $643,226.85 | |
Aug. 4, 2023 | CFO | 3,460 | $185.85 | Sell | $643,041.00 | |
April 27, 2023 | CFO | 977 | $194.59 | Sell | $190,114.43 | |
April 27, 2023 | CEO | 7,615 | $194.59 | Sell | $1,481,802.85 | |
April 27, 2023 | President | 2,392 | $194.59 | Sell | $465,459.28 | |
April 27, 2023 | EVP | 1,476 | $194.59 | Sell | $287,214.84 | |
April 27, 2023 | CMO | 1,839 | $194.59 | Sell | $357,851.01 | |
April 6, 2023 | EVP | 3,500 | $210.00 | Sell | $735,000.00 | |
March 3, 2023 | CMO | 18,072 | $200.00 | Sell | $3,614,400.00 | |
Feb. 2, 2023 | EVP | 1,675 | $226.01 | Sell | $378,566.75 | |
Aug. 5, 2022 | EVP | 1,841 | $218.16 | Sell | $401,632.56 | |
Aug. 3, 2022 | EVP | 1,754 | $210.00 | Sell | $368,340.00 | |
July 5, 2022 | EVP | 1,754 | $150.00 | Sell | $263,100.00 | |
April 1, 2022 | Director | 15,000 | $170.69 | Sell | $2,560,350.00 | |
Dec. 23, 2021 | Insider | 2,879 | $190.93 | Sell | $549,687.47 | |
Nov. 12, 2021 | CEO | 33,978 | $171.52 | Sell | $5,827,906.56 | |
Aug. 13, 2021 | CEO | 33,979 | $199.78 | Sell | $6,788,324.62 | |
Aug. 6, 2021 | COO | 53,064 | $199.00 | Sell | $10,559,736.00 | |
Aug. 5, 2021 | EVP | 10,000 | $188.95 | Sell | $1,889,500.00 | |
July 12, 2021 | EVP | 6,812 | $178.96 | Sell | $1,219,075.52 | |
June 18, 2021 | Insider | 14,708 | $175.00 | Sell | $2,573,900.00 | |
June 9, 2021 | EVP | 1,734 | $154.00 | Sell | $267,036.00 | |
May 13, 2021 | CEO | 33,979 | $130.78 | Sell | $4,443,773.62 | |
April 21, 2021 | Insider | 2,732 | $136.95 | Sell | $374,147.40 | |
April 19, 2021 | Insider | 3,706 | $137.67 | Sell | $510,205.02 | |
Jan. 12, 2021 | COO | 3,125 | $161.00 | Sell | $503,125.00 | |
Jan. 12, 2021 | EVP | 14,941 | $160.20 | Sell | $2,393,548.20 | |
Dec. 18, 2020 | Director | 15,000 | $140.00 | Sell | $2,100,000.00 | |
Nov. 25, 2020 | Director | 30,000 | $124.89 | Sell | $3,746,700.00 | |
Sept. 29, 2020 | Insider | 971 | $140.00 | Sell | $135,940.00 | |
Sept. 9, 2020 | President | 44,530 | $123.23 | Sell | $5,487,431.90 | |
Aug. 20, 2020 | CEO | 34,765 | $136.13 | Sell | $4,732,559.45 | |
July 13, 2020 | EVP | 47,250 | $160.67 | Sell | $7,591,657.50 | |
July 9, 2020 | COO | 11,236 | $161.00 | Sell | $1,808,996.00 | |
July 7, 2020 | President | 22,265 | $159.99 | Sell | $3,562,177.35 | |
May 20, 2020 | CEO | 34,765 | $143.22 | Sell | $4,979,043.30 | |
May 6, 2020 | President | 22,265 | $149.99 | Sell | $3,339,527.35 |
Insiders are both buying and selling Alnylam Pharmaceuticals Inc stock.
The insider traders at Alnylam Pharmaceuticals Inc are: John Maraganore, Akshay Vaishnaw, Yvonne Greenstreet, Laurie Keating, Barry E Greene, Paul Schimmel, Philip A Sharp, Michael Mason, Laurence Reid, Pushkal Garg, Dennis A Ausiello, Tolga Tanguler, Steven M Paul, Sanofi, Kevin P Starr, Jeffrey V Poulton, Michael W Bonney, Phillip A Sharp, David E I Pyott, Indrani Lall Franchini, Amy W Schulman, John Clarke, Kevin Joseph Fitzgerald, Kevin P. Starr, Marsha Fanucci, Philip A. Sharp, and David-Alexandre C Gros
The most active insider trader at Alnylam Pharmaceuticals Inc is John Maraganore with 23 trades.
John Maraganore has sold the most Alnylam Pharmaceuticals Inc stock with a total value of $118,340,674.92.
Sanofi has bought the most Alnylam Pharmaceuticals Inc stock with a total value of $89,326,528.48.
The most recent insider trade for Alnylam Pharmaceuticals Inc was on Aug. 20, 2024.
The single biggest insider buy for Alnylam Pharmaceuticals Inc was from Sanofi with a total value of $23,036,682.24 on March 25, 2014.
The single biggest insider sell for Alnylam Pharmaceuticals Inc was from Akshay Vaishnaw with a total value of $12,672,077.40 on March 14, 2018.